Infection and Chemotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 44.0% | 0.719 | Q2 | 73.7% |
| 2024 | 2.9 | Q2 | 62.8% | 0.685 | Q2 | 72.9% |
| 2023 | 2.8 | Q2 | 54.5% | 0.698 | Q2 | 75.6% |
| 2022 | 4.2 | 73.6% | 0.831 | Q2 | 81.6% | |
| 2021 | — | 39.6% | 0.863 | Q2 | 83.2% | |
| 2020 | — | — | 0.724 | Q2 | 77.0% | |
| 2019 | — | — | 0.771 | Q2 | 79.4% | |
| 2018 | — | — | 0.776 | Q2 | 77.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2092-6448
ISSN
2093-2340
country
KRcoverage
2011-2025